Allianz Asset Management GmbH Decreases Holdings in The Clorox Company $CLX

Allianz Asset Management GmbH decreased its position in The Clorox Company (NYSE:CLX) by 19.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 112,951 shares of the company’s stock after selling 27,498 shares during the quarter. Allianz Asset Management GmbH’s holdings in Clorox were worth $13,927,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of CLX. Nomura Asset Management Co. Ltd. increased its stake in shares of Clorox by 9.0% during the second quarter. Nomura Asset Management Co. Ltd. now owns 335,514 shares of the company’s stock valued at $40,285,000 after buying an additional 27,639 shares during the period. Hudson Bay Capital Management LP purchased a new stake in Clorox in the second quarter worth $8,568,000. Vanguard Personalized Indexing Management LLC boosted its holdings in Clorox by 64.2% in the third quarter. Vanguard Personalized Indexing Management LLC now owns 25,732 shares of the company’s stock valued at $3,173,000 after acquiring an additional 10,065 shares in the last quarter. Vise Technologies Inc. purchased a new position in Clorox during the 2nd quarter valued at $328,000. Finally, Brookstone Capital Management increased its position in Clorox by 1,395.4% during the 3rd quarter. Brookstone Capital Management now owns 94,332 shares of the company’s stock valued at $11,631,000 after purchasing an additional 88,024 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently commented on CLX shares. Citigroup raised their target price on shares of Clorox from $109.00 to $115.00 and gave the stock a “neutral” rating in a research report on Wednesday. Zacks Research upgraded shares of Clorox from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. UBS Group raised their price objective on shares of Clorox from $115.00 to $121.00 and gave the stock a “neutral” rating in a report on Wednesday. Weiss Ratings cut Clorox from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Clorox from $114.00 to $112.00 and set a “hold” rating for the company in a research report on Wednesday. One investment analyst has rated the stock with a Buy rating, ten have issued a Hold rating and five have issued a Sell rating to the stock. According to MarketBeat, Clorox has an average rating of “Reduce” and a consensus price target of $117.93.

Clorox Price Performance

Shares of CLX opened at $119.52 on Friday. The Clorox Company has a fifty-two week low of $96.66 and a fifty-two week high of $159.04. The firm’s 50-day simple moving average is $105.83 and its two-hundred day simple moving average is $113.86. The stock has a market cap of $14.45 billion, a PE ratio of 19.53, a price-to-earnings-growth ratio of 0.58 and a beta of 0.59. The company has a debt-to-equity ratio of 71.03, a quick ratio of 0.50 and a current ratio of 0.74.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 383.01% and a net margin of 11.17%.The business’s revenue for the quarter was down .8% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.55 earnings per share. Analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be issued a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.1%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s payout ratio is 81.05%.

Insider Activity at Clorox

In related news, Director Pierre R. Breber purchased 4,000 shares of Clorox stock in a transaction dated Friday, November 21st. The stock was purchased at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the acquisition, the director directly owned 13,000 shares of the company’s stock, valued at $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.63% of the company’s stock.

More Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Morgan Stanley raised its price target on CLX to $136 (maintained equal-weight), citing valuation/earnings dynamics — a catalyst supporting the stock’s rally. Clorox (NYSE:CLX) Price Target Raised to $136.00 at Morgan Stanley
• Positive Sentiment: Investor write-ups are bullish: a Seeking Alpha piece frames CLX as a defensive, dividend-rich value after “solid” Q2 results and attractive valuation — supporting buy interest from income-focused investors. Clorox: Solid Q2 Results And Cheap Valuation MakesThis Defensive Dividend Stock A Strong Buy
• Neutral Sentiment: TD Cowen nudged its price target to $111 and kept a Hold rating — a modest recalibration that tempers upside expectations despite the recent positive headlines. TD Cowen Adjusts Clorox Price Target
• Neutral Sentiment: Company reported mixed Q2 results and reaffirmed its 2026 outlook — revenue roughly flat year-over-year and an EPS miss by a few cents; reassurances on the outlook limit downside but leave questions on near-term margin recovery. Clorox Posts Mixed Q2 Results, Reaffirms 2026 Outlook
• Neutral Sentiment: Management is weighing a potential GOJO acquisition and finishing an ERP implementation; strategic moves could boost long-term growth but add execution risk in the near term. Clorox Weighs GOJO Deal And ERP Finish Against Softer Earnings
• Neutral Sentiment: Q2 earnings call transcript is available for deeper read on management commentary around pricing, cost savings and margin plans — useful for gauging execution risk. Clorox (CLX) Q2 2026 Earnings Call Transcript
• Negative Sentiment: Some brokerages have a consensus “Reduce” rating on CLX, which may cap upside as institutional flows react to conservative guidance and margin concerns. The Clorox Company Given Consensus Rating of “Reduce” by Brokerages
• Negative Sentiment: BofA flagged margin uncertainty after the Q2 EPS miss — a reminder that cost and margin recovery, not just revenue, will drive forecast revisions and investor sentiment. BofA Flags Margin Uncertainty for Clorox After Q2 Earnings Miss
• Neutral Sentiment: A Zacks piece highlights using its Earnings ESP tool to find staples stocks that might beat — general market research, not CLX-specific guidance, but could affect short-term trading interest. Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.